UV-induced DNA repair in hairy cell leukaemia patients

Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patients.

ESMO open·2025

Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials.

ESMO open·2024

The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

Characterization of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiency.

Haemophilia : the official journal of the World Federation of Hemophilia·2014

Identification of a novel large deletion in a patient with severe factor V deficiency using an in-house F5 MLPA assay.

Haemophilia : the official journal of the World Federation of Hemophilia·2014

CD44-galectin-9 and TGF-β-Smad3 Pathways Form an Autocrine Loop which Facilitates Human Cancer Cells to Self-Regulate their Immune Evasion Machinery.

Cancer letters·2026

Modulation of Ferroptosis Bridges Radiotherapy and Immunotherapy to Improve Cancer Treatment Outcomes.

Cancer letters·2026

Therapeutic potential of colchicine-binding site inhibitors in breast cancer brain metastasis.

Cancer letters·2026

Epithelial HSD11β2 as an immunometabolic checkpoint in head and neck cancer: Restoring local steroid inactivation reinvigorates T cell immunity.

Cancer letters·2026

Lack of tumor-derived LCN2 sensitizes pancreatic cancer cells to ferroptosis induction.

Cancer letters·2026

Visualizing and Targeting Tumor-Associated Neutrophils: Advanced Imaging, Therapeutic Reprogramming, and Cell-Based Delivery for Precision Oncology.

Cancer letters·2026

Co-occurrence of GATA2 deficiency and probable constitutional mosaic STAG2 alteration in a young adult with myelodysplastic syndrome: a case report.

Frontiers in medicine·2026

Epstein-Barr virus reactivation and post-transplant lymphoproliferative disease risk deserve a place in the JAK inhibitor toxicity profile. Comment on: "Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications".

Haematologica·2026

Venous Thromboembolism in Patients Treated with Everolimus: Insights from a Case Series and the French Pharmacovigilance Database.

Current vascular pharmacology·2026

Hepatocellular Carcinoma With JAK1 Mutations Harbors Distinct Histologic Features and Specific Mutational Hotspots in an Asian Cohort.

The American journal of surgical pathology·2026

TH/TRs-COL11A2 Axis Mediates Loss of a Differentiated Astrocyte State in Hypogyrified Brains.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Functional contribution of Epstein-Barr virus BARF1 residues 35-39 to viable cell maintenance under serum deprivation and tumor formation.

Virus genes·2026

Related Experiment Videos

UV-induced DNA repair in hairy cell leukaemia patients

Related Concept Videos

Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patients.

Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials.

The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy.

Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial.

Characterization of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiency.

Identification of a novel large deletion in a patient with severe factor V deficiency using an in-house F5 MLPA assay.

CD44-galectin-9 and TGF-β-Smad3 Pathways Form an Autocrine Loop which Facilitates Human Cancer Cells to Self-Regulate their Immune Evasion Machinery.

Modulation of Ferroptosis Bridges Radiotherapy and Immunotherapy to Improve Cancer Treatment Outcomes.

Therapeutic potential of colchicine-binding site inhibitors in breast cancer brain metastasis.

Epithelial HSD11β2 as an immunometabolic checkpoint in head and neck cancer: Restoring local steroid inactivation reinvigorates T cell immunity.

Lack of tumor-derived LCN2 sensitizes pancreatic cancer cells to ferroptosis induction.

Visualizing and Targeting Tumor-Associated Neutrophils: Advanced Imaging, Therapeutic Reprogramming, and Cell-Based Delivery for Precision Oncology.

Co-occurrence of GATA2 deficiency and probable constitutional mosaic STAG2 alteration in a young adult with myelodysplastic syndrome: a case report.

Epstein-Barr virus reactivation and post-transplant lymphoproliferative disease risk deserve a place in the JAK inhibitor toxicity profile. Comment on: "Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications".

Venous Thromboembolism in Patients Treated with Everolimus: Insights from a Case Series and the French Pharmacovigilance Database.

Hepatocellular Carcinoma With JAK1 Mutations Harbors Distinct Histologic Features and Specific Mutational Hotspots in an Asian Cohort.

TH/TRs-COL11A2 Axis Mediates Loss of a Differentiated Astrocyte State in Hypogyrified Brains.

Functional contribution of Epstein-Barr virus BARF1 residues 35-39 to viable cell maintenance under serum deprivation and tumor formation.

Related Experiment Videos

UV-induced DNA repair in hairy cell leukaemia patients

Abstract:

Related Concept Videos

Related Articles